Fan Zhang

Title: Innovations in Brain Tumor Treatment by Inventor Fan Zhang

Introduction

Fan Zhang is an accomplished inventor based in Baltimore, MD (US). He has made significant contributions to the field of medical science, particularly in the treatment of brain tumors. His innovative approach focuses on the use of dendrimers for targeted drug delivery, which has the potential to improve therapeutic outcomes for patients.

Latest Patents

Fan Zhang holds a patent for "Selective dendrimer delivery to brain tumors." This patent describes a composition comprising poly(amidoamine) (PAMAM) hydroxyl-terminated dendrimers that are covalently linked to therapeutic, prophylactic, or diagnostic agents. These dendrimers are designed to treat or alleviate symptoms of brain tumors. Notably, the dendrimers demonstrate high uptake into the brain, allowing for selective delivery through the blood-brain barrier (BBB) of various agents, including chemotherapeutic and immunotherapeutic compounds. This innovative method provides a means for simultaneous delivery of different classes of compounds, enhancing treatment efficacy.

Career Highlights

Throughout his career, Fan Zhang has worked with prestigious institutions such as The Johns Hopkins University and Kennedy Krieger Institute, Inc. His work has been instrumental in advancing the understanding and treatment of brain tumors. His dedication to research and innovation has positioned him as a leading figure in his field.

Collaborations

Fan Zhang has collaborated with notable colleagues, including Kannan Rangaramanujam and Betty M. Tyler. These partnerships have contributed to the development of groundbreaking solutions in medical science.

Conclusion

Fan Zhang's innovative work in the field of brain tumor treatment exemplifies the impact of targeted drug delivery systems. His contributions continue to pave the way for advancements in medical therapies, ultimately improving patient outcomes.